Hair loss in Telmisartan - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Hair loss, when it was recovered, drug effectiveness, race, and more among people who take Telmisartan (telmisartan). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.

What is Hair loss?

Hair loss is found to be associated with 2,411 drugs and 3,517 conditions by eHealthMe. Check the latest studies of Hair loss.

On Aug, 10, 2026

14 people who have Hair loss while taking Telmisartan were studied.

Severity of Hair loss *:

least: 8.33 %
moderate: 41.67 %
severe: 33.33 %
most severe: 16.67 %

When people recovered from Hair loss *:

while on drug: 0.0 %
after off the drug: 11.11 %
not yet: 88.89 %

Effectiveness of Telmisartan *:

not at all: 0.0 %
somewhat: 18.18 %
moderate: 45.45 %
high: 36.36 %
very high: 0.0 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 10 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 90 %

Time on Telmisartan *:

Gender of people when taking Telmisartan *:

female: 78.57 %
male: 21.43 %

Age of people when taking Telmisartan *:

Conditions people have *:

High Blood Cholesterol: 4 people, 28.57%
Inflammation: 2 people, 14.29%
Type 2 Diabetes: 1 person, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.14%
Essential Hypertension (primary hypertension): 1 person, 7.14%
Erection Problems: 1 person, 7.14%
Drug-Induced Cholestasis (drug induced - bile cannot flow from the liver to the duodenum): 1 person, 7.14%
Depression: 1 person, 7.14%
Colitis (inflammation of colon): 1 person, 7.14%

Other drugs people take besides Telmisartan *:

Other side effects people have besides Hair loss *:

Fatigue (feeling of tiredness): 4 people, 28.57%
Dizziness: 2 people, 14.29%
Weakness: 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Arrhythmias (irregular heartbeat): 1 person, 7.14%
Asthma: 1 person, 7.14%
Bradycardia (abnormally slow heart action): 1 person, 7.14%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.14%
Constipation: 1 person, 7.14%
Cough: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and have Hair loss?

Check whether Hair loss is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Hair loss in Telmisartan

How the study uses the data?

The study is based on telmisartan (the active ingredients of Telmisartan). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.